MPTP’s Pathway of Toxicity Indicates Central Role of Transcription Factor SP1

Archives of Toxicology

Volumn 89, Issue 5, 2015, Pages 743-755

  Maertens, Alexandra ^a   Luechtefeld, Thomas ^a   Kleensang, Andre ^a   Hartung, Thomas ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

GRN; MPTP; Parkinson s disease; Pathway of toxicity; SP1; WGCNA

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; INTOXICATION; MALE; MICROARRAY ANALYSIS; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MPTP POISONING; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 84937763669     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-015-1509-6     Document Type: Article

References (45)

1. Bouhifd M, Hogberg HT, Kleensang A, Maertens A, Zhao L, Hartung T (2014) Mapping the human toxome by systems toxicology. Basic Clin Pharmacol Toxicol 115:1–8. doi:10.1111/bcpt.12198
2. Caberoy NB, Alvarado G, Li W (2012) Tubby regulates microglial phagocytosis through MerTK. J Neuroimmunol 252:40–48
3. Cappelletti G, Pedrotti B, Maggioni MG, Maci R (2001) Microtubule assembly is directly affected by MPP(+)in vitro. Cell Biol Int 25:981–984. doi:10.1006/cbir.2001.0772
4. Chen S, Lu FF, Seeman P, Liu F (2012) Quantitative proteomic analysis of human substantia nigra in Alzheimer’s Disease, Huntington’s disease and Multiple sclerosis. Neurochem Res 37:2805–2813. doi:10.1007/s11064-012-0874-2
5. Chuang JY, Wu CH, Lai MD, Chang WC, Hung JJ (2009) Overexpression of Sp1 leads to p53 dependent apoptosis in cancer cells. Int J Cancer 125:2066–2076. doi:10.1002/ijc.24563
6. Courey AJ, Holtzman DA, Jackson SP, Tjian R (1989) Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59:827–836. doi:10.1016/0092-8674(89)90606-5
7. Davis S, Meltzer PS (2007) GEOquery: a bridge between the gene expression omnibus (GEO) and bioconductor. Bioinformatics 23:1846–1847
8. Dehay B, Bove J, Rodriguez-Muela N, Perier C, Recasens A, Boya P, Vila M (2010) Pathogenic lysosomal depletion in Parkinson’s disease. J Neurosci 30:12535–12544. doi:10.1523/JNEUROSCI.1920-10.2010
9. Deniaud E, Baguet J, Chalard R, Blanquier B, Brinza L, Meunier J, Michallet M-C, Laugraud A, Ah-Soon C, Wierinckx A, Castellazzi M, Lachuer J, Gautier C, Marvel J, Leverrier Y (2009) Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition. PLoS One 4:e7035. doi:10.1371/journal.pone.0007035
10. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3. http://genomebiology.com/2003/4/9/R60
11. Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N (2011) Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease. PLoS Genet 7:e1002141. doi:10.1371/journal.pgen.1002141
12. Fan Y, Kong H, Shi X, Sun X, Ding J, Wu J, Hu G (2008) Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyrindine and astrocytic modulation. Neurobiol Aging 29:1226–1236. doi:10.1016/j.neurobiolaging.2007.02.015
13. Hartung T (2009) Toxicology for the twenty-first century. Nature 460:208–212. doi:10.1038/460208a
14. Hartung T, McBride M (2011) Food for thought… on mapping the human toxome. Altex 28:83–93. doi:10.14573/altex.2011.2.083
15. Hoang T, Choi D-K, Nagai M, Wu D-C, Nagata T, Prou D, Wilson GL, Vila M, Jackson-Lewis V, Dawson VL, Dawson TM, Chessel M-F, Przedborski S (2009) Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. Free Radical Biol Med 47:1049–1056. doi:10.1016/j.freeradbiomed.2009.07.013
16. Ivatt R, Whitworth AJ (2014) SREBF1 links lipogenesis to mitophagy and sporadic Parkinson’s disease. Autophagy 10:33–34. doi:10.4161/auto.29642
17. Janz R, Sudhof TC, Hammer RE, Unni V, Siegelbaum SA, Bolshakov VY (1999) Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron 24:687–700
18. Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Wu D, Peng PL, Guan J-S, Lee B-H, Moy LY, Giusti P, Broodie N, Mazitschek R, Delalle I, Haggarty SJ, Neve RL, Lu YM, Tsai L-H (2008) Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60:803–817. doi:10.1016/j.neuron.2008.10.015
19. Kleensang A, Maertens A, Rosenberg M, Fitzpatrick S, Lamb J, Auerbach S, Brennan R, Crofton KM, Gordon B, Fornace AJ Jr, Gaido K, Gerhold D, Haw R, Henney A, Ma’ayan A, McBride M, Monti S, Ochs MF, Pandey A, Sharan R, Stierum R, Tugendreich S, Willett C, Wittwehr C, Xia J, Patton GW, Arvidson K, Bouhifd M, Hogberg HT, Luechtefeld T, Smirnova L, Zhao L, Adeleye Y, Kanehisa M, Carmichael P, Andersen EM, Hartung T (2014) Pathways of Toxicity. Altex 31:53–61. doi:10.14573/altex.1309261
20. Krug AK, Gutbier S, Zhao L, Pöltl D, Kullmann C, Ivanova V, Förster S, Jagtap S, Meiser J, Leparc G, Schildknecht S, Adam M, Hiller K, Farhan H, Brunner T, Hartung T, Sachinidis A, Leist M (2014) Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+). Cell Death Dis 5:e1222. doi:10.1038/cddis.2014.166
21. Langfelder P, Horvath S (2007) Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol 1:54. doi:10.1186/1752-0509-1-54
22. Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma 9:559. doi:10.1186/1471-2105-9-559
23. Langfelder P, Zhang B, Horvath S (2008) Defining clusters from a hierarchical cluster tree: the dynamic tree cut package for R. Bioinformat 24:719–720. doi:10.1093/bioinformatics/btm563
24. Mi H, Muruganujan A, Casagrande JT, Thomas PD (2013) Large-scale gene function analysis with the PANTHER classification system. Nat Protoc 8:1551–1566. doi:10.1038/nprot.2013.092
25. Miller RM et al (2004) Dysregulation of gene expression in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned mouse substantia nigra. J neurosci 24:7445–7454
26. Naoi M, Maruyama W, Inaba-Hasegawa K (2012) Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival. Curr Top Med Chem 12:2177–2188. doi:10.2174/1568026611212200006
27. Perier C, Vila M (2012) Mitochondrial biology and Parkinson’s disease. Cold Spring Harb Perspect Med 2:a009332. doi:10.1101/cshperspect.a009332
28. Pollio G, Hoozemans JJ, Andersen CA, Roncarati R, Rosi MC, van Haastert ES, Seredenina T, Diamanti D, Gotta S, Fiorentini A, Magnoni L, Raggiaschi R, Rozemuller AJ, Casamenti F, Caricasole A, Terstappen GC (2008) Increased expression of the oligopeptidase THOP1 is a neuroprotective response to Abeta toxicity. Neurobiol Dis 31:145–158. doi:10.1016/j.nbd.2008.04.004
29. Qiu Z, Norflus F, Singh B, Swindell MK, Buzescu R, Bejarano M, Chopra R, Zucker B, Benn CL, DiRocco DP, Cha JH, Ferrante RJ, Hersch SM (2006) Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. J Biol Chem 281:16672–16680. doi:10.1074/jbc.M511648200
30. Quackenbush J (2003) Genomics. Microarrays–guilt by association. Science 302:240–241. doi:10.1126/science.1090887
31. Ren Y, Liu W, Jiang H, Jiang Q, Feng J (2005) Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem 280:34105–34112. doi:10.1074/jbc.M503483200
32. Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M, Flemington E, Azizkhan-Clifford J, Ferrante RJ, Ratan RR (2003) Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci USA 100:4281–4286. doi:10.1073/pnas.0737363100
33. Santpere G, Nieto M, Puig B, Ferrer I (2006) Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies. Neurosci Lett 397:30–34. doi:10.1016/j.neulet.2005.11.062
34. Schober A (2004) Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res 318:215–224. doi:10.1007/s00441-004-0938-y
35. Severin J, Waterhouse AM, Kawaji H, Lassmann T, van Nimwegen E, Balwierz PJ, de Hoon MJ, Hume DA, Carninci P, Hayashizaki Y, Suzuki H, Daub CO, Forrest AR (2009) FANTOM4 EdgeExpressDB: an integrated database of promoters, genes, microRNAs, expression dynamics and regulatory interactions. Genome Biol 10:R39. doi:10.1186/gb-2009-10-4-r39
36. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504. doi:10.1101/gr.1239303
37. Snyder SH, D’Amato RJ (1986) MPTP: a neurotoxin relevant to the pathophysiology of Parkinson’s disease—The 1985 George C. Cotzias Lecture. Neurology 36:250
38. Sterky FH, Hoffman AF, Milenkovic D, Bao B, Paganelli A, Edgar D, Wibom R, Lupica CR, Olson L, Larsson NG (2012) Altered dopamine metabolism and increased vulnerability to MPTP in mice with partial deficiency of mitochondrial complex I in dopamine neurons. Hum Mol Gen 21:1078–1089. doi:10.1093/hmg/ddr537
39. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550. doi:10.1073/pnas.0506580102
40. Wang J, Bannon MJ (2005) Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J Neurochem 93:474–482. doi:10.1111/j.1471-4159.2005.03051.x
41. Ye Q, Zhang X, Huang B, Zhu Y, Chen X (2013) Astaxanthin suppresses MPP-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar Drugs 11:1019–1034. doi:10.3390/md11041019
42. Yip AM, Horvath S (2007) Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinforma 8:22. doi:10.1186/1471-2105-8-22
43. Zhang CZ, Chen GG, Lai P (2010) Transcription factor ZBP-89 in cancer growth and apoptosis. Biochim Biophys Acta Rev Cancer 1806:36–41. doi:10.1016/j.bbcan.2010.03.002
44. Zhong WX, Wang YB, Peng L, Ge XZ, Zhang J, Liu SS, Zhang XN, Xu ZH, Chen Z, Luo JH (2012) Lanthionine synthetase C-like protein 1 interacts with and inhibits cystathionine beta-synthase: a target for neuronal antioxidant defense. J Biol Chem 287:34189–34201. doi:10.1074/jbc.M112.383646
45. Zhu QS, Chen K, Shih JC (1994) Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. J Neurosci 14:7393–7403